ICMR drops plasma therapy from COVID-19 treatment guidelines
The Hindu
Trials had found no significant benefit from the use of plasma
The use of convalescent plasma has been dropped from the recommended treatment guidelines for COVID-19, according to late Monday advisory from the Indian Council of Medical Research (ICMR). The National Task Force of the ICMR, along with experts from the Health Ministry, periodically updates guidelines on recommended modes of treatment. Registered Doctors anywhere, however, aren’t bound by the Task Force recommendations. Though a trial by the ICMR on 400 patients last year — called the PLACID trial — had found no significant benefit from the use of plasma it continued to find a place in the recommended guidelines, in ‘off label’ use.More Related News